In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
about
Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (WNS) in batsMelanized fungi in human diseaseFusarium infections in immunocompromised patientsInvasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal PathogenSusceptibility of Pneumocystis to echinocandins in suspension and biofilm culturesPropofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cellMultilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditisAnidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.Epidemiology of invasive fungal infections in the mediterranean areaMicafungin in the treatment of invasive candidiasis and invasive aspergillosisNew Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium speciesDigestive fungal flora in asymptomatic subjects in Bobo-Dioulasso, Burkina Faso.Human Fungal Pathogens of Mucorales and Entomophthorales.Black Molds and Melanized Yeasts Pathogenic to HumansComparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.Anidulafungin in the treatment of invasive fungal infections.Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.Resistance to echinocandin-class antifungal drugs.Micafungin activity against Candida albicans with diverse azole resistance phenotypes.In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model.Posaconazole in the management of refractory invasive fungal infections.Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methodsMulticenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.Antifungal resistance and new strategies to control fungal infections.Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.Determination of MICs of aminocandin for Candida spp. and filamentous fungi.Microplate alamarBlue assay for Paracoccidioides susceptibility testing.Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by useImproved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.
P2860
Q21560851-B7FE020B-45D4-42AE-B9F2-38F8B08167ACQ24633163-A0025F65-614B-45B7-A65D-819C916794C6Q24685627-DDFF9A22-48B6-416C-8A38-7B4DD3CD498AQ28071847-6A5A4DC9-B6BE-47AE-BA18-4A49CA7CC4C8Q28477349-DEF48087-7B81-4B51-AA45-D6C36B8EF8E5Q33315163-B1E80298-D1A2-470A-ACE7-012AB7375DAFQ33622915-032BE04C-9D77-4B2B-AAF3-269E7E55CDE8Q33803108-C81A3453-57EB-4394-B6BF-D7A3E6DA4B29Q34036214-E6563161-5375-43C2-96FA-3DF7BAB035F0Q35010686-20A05387-A937-480A-955B-9D2A5166C567Q35026516-14D3D5AA-4217-4E0E-8167-1B76E02D1458Q35139501-5169F869-06BB-48F0-93CA-5A98B534FB1DQ35237228-1AD8F927-A42E-4DE9-A279-8752FC774810Q35245238-550A4710-A3C1-45D8-89BB-D26B82D7B0AAQ35408323-16488F24-8DFC-4F60-9581-5A2A250557E5Q35806170-712BE1B6-89E6-4B52-BDF0-F1D6901926A6Q35913719-87AEEB10-2480-484E-A3EE-FF8A3222DC30Q36425025-26133CDC-B4BD-4B95-B25A-57AE2592547DQ36822941-4634B175-C660-45B1-88F1-12B7225946EAQ36845482-B8F5FA5A-D898-4C32-84AA-B657791A7883Q36849595-7D57BA5F-D075-4D64-A70F-ECCFBD47636AQ36867925-AE9E81AC-2482-49A0-9AD8-C5BE220FFD13Q36932989-B53B3BCA-C746-4B6C-85E4-92F00B5C9198Q37052755-431881A4-F45E-48D1-BF8F-3982392D2539Q37114436-14A234A0-4ED1-483C-93AB-195AEE373424Q37374949-8B6B0610-D1FE-4750-ACD7-BE7013828006Q37544819-75A0E14E-E77C-431F-AA77-EDBA55977CB8Q38726054-64A4F23C-F26F-4271-9883-E3CEA1CF40BEQ39686624-36E1A5D6-C918-4C26-BFA4-A1A8B4BF3751Q39751373-F24CF9F2-0773-4392-83D4-947974EDFCC9Q39763435-84F43A7D-7C26-4847-9F73-583FDA5AEFD3Q40743249-20A0A0B5-7331-4EF0-87E8-0CBE2BAB0AB8Q41071178-DB33122C-2353-4C50-B296-D43451CBA3B2Q41158301-0A95417E-9510-4121-9348-C7179A7BA184Q41361550-823669A6-6480-4EA9-A0A8-F7B59596887AQ41772012-139130C6-368F-43A8-BCD8-EF2693031737Q41810114-FAF55C27-365A-4062-B5F0-BA3C2446E095Q41842788-3F8C1349-9BF3-4BE7-BA86-F4CD98FFA427Q41969487-6B5AD650-02AE-4896-AD86-CCCCF1A6A901Q42035300-C82EAD7E-82BC-4B6A-B3B9-89A6403876A2
P2860
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
In vitro antifungal activities ...... tes: review of the literature.
@ast
In vitro antifungal activities ...... tes: review of the literature.
@en
type
label
In vitro antifungal activities ...... tes: review of the literature.
@ast
In vitro antifungal activities ...... tes: review of the literature.
@en
prefLabel
In vitro antifungal activities ...... tes: review of the literature.
@ast
In vitro antifungal activities ...... tes: review of the literature.
@en
P1476
In vitro antifungal activities ...... tes: review of the literature.
@en
P2093
Ana Espinel-Ingroff
P304
P577
2003-12-01T00:00:00Z